Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage

Author:

JACQUES Suzanne L.1,KULIOPULOS Athan1

Affiliation:

1. Molecular Cardiology Research Institute, Division of Hematology/Oncology, Tufts-New England Medical Center and Departments of Medicine and Biochemistry, Tufts University School of Medicine, Boston, MA 02111, U.S.A.

Abstract

Thrombin activation of human platelets is mediated by the high-affinity PAR1 (protease-activated receptor-1) and the low-affinity PAR4 receptor. PAR1 and PAR4 exhibit markedly disparate kinetics of activation that likely reflect differences in the macromolecular association of thrombin with their respective N-terminal extracellular domains (exodomains). Here we examine the mechanism of initial thrombin binding and cleavage of the high- and low-affinity PAR exodomains using steady-state kinetic analyses. We showed that the PAR4 exodomain lacks the functional hirudin-like sequence found in PAR1 and does not bind exosite I to cause allosteric activation or inhibition of thrombin. Instead, PAR4 contains an anionic cluster, Asp57…Asp59…Glu62…Asp65 (DDED), in its exodomain, which slows the dissociation of PAR4 from the cationic thrombin. The analogous anionic residues in the PAR1 exodomain do not influence affinity for thrombin. Although PAR4 is cleaved more slowly than PAR1 on the cell surface, peptides containing the PAR4 P4-P1 active-site-interacting sequence, Pro45-Ala-Pro-Arg (PAPR), are efficiently cleaved due to the optimal placement of dual prolines at positions P4 and P2. In comparison, thrombin has low affinity and slow cleavage rates for peptides that have a P3 proline as occurs in human PAR3. Thus, to compensate for the lack of exosite I binding, PAR4 utilizes proline residues in its P4-P1 sequence to provide high-affinity interactions with the active site and an anionic cluster to slow dissociation from the cationic thrombin.

Publisher

Portland Press Ltd.

Subject

Cell Biology,Molecular Biology,Biochemistry

Cited by 88 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Protease activated receptor-4: ready to be part of the antithrombosis spectrum;Current Opinion in Hematology;2024-05-30

2. Antiplatelet strategies: past, present, and future;Journal of Thrombosis and Haemostasis;2023-12

3. Species Differences in Platelet Protease-Activated Receptors;International Journal of Molecular Sciences;2023-05-05

4. Protease-activated receptors in health and disease;Physiological Reviews;2023-01-01

5. Inhibitors of protease-activated receptor 4 (PAR4): a review of recent patents (2013–2021);Expert Opinion on Therapeutic Patents;2022-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3